{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:32:03Z","timestamp":1792794723238,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jiac.2022.11.016","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T20:44:51Z","timestamp":1670273091000},"page":"361-366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Miliary tuberculosis-associated hemophagocytic lymphohistiocytosis with a high level of soluble interleukin-2 receptor successfully treated with concomitant recombinant thrombomodulin: A case report"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1891-9838","authenticated-orcid":false,"given":"Hideki","family":"Uryu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0693-3501","authenticated-orcid":false,"given":"Kazuyoshi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5539-9811","authenticated-orcid":false,"given":"Yu","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Tsujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiko","family":"Hata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshinori","family":"Oinuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Yahagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2022.11.016_bib1","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(13)61048-X","article-title":"Adult haemophagocytic syndrome","volume":"383","author":"Ramos-Casals","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jiac.2022.11.016_bib2","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1182\/blood-2006-01-021253","article-title":"Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5","volume":"109","author":"Murase","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jiac.2022.11.016_bib3","first-page":"203","article-title":"Miliary tuberculosis with markedly elevated soluble interleukin-2 receptor levels mimicking intravascular large B-cell lymphoma","volume":"60","author":"Kaiume","year":"2019","journal-title":"Rinsho Ketsueki"},{"key":"10.1016\/j.jiac.2022.11.016_bib4","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.jiac.2016.02.002","article-title":"Disseminated tuberculosis with acute respiratory distress syndrome lacking granuloma formation in the lung","volume":"22","author":"Nakao","year":"2016","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2022.11.016_bib5","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1160\/TH04-09-0562","article-title":"Mycobacterium tuberculosis inducing disseminated intravascular coagulation","volume":"93","author":"Wang","year":"2005","journal-title":"Thromb Haemostasis"},{"key":"10.1016\/j.jiac.2022.11.016_bib6","first-page":"31","article-title":"Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial","volume":"vol. 5","author":"Saito","year":"2007"},{"key":"10.1016\/j.jiac.2022.11.016_bib7","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.thromres.2013.03.008","article-title":"Impact of recombinant soluble thrombomodulin (thrombomodulin alfa) on disseminated intravascular coagulation","volume":"131","author":"Mimuro","year":"2013","journal-title":"Thromb Res"},{"key":"10.1016\/j.jiac.2022.11.016_bib8","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jiac.2022.11.016_bib9","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S1473-3099(06)70524-2","article-title":"Tuberculosis-associated haemophagocytic syndrome","volume":"6","author":"Brastianos","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiac.2022.11.016_bib10","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0929-6646(08)60158-8","article-title":"Hemophagocytic syndrome in miliary tuberculosis presenting with noncaseating granulomas in bone marrow and liver","volume":"107","author":"Lee","year":"2008","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jiac.2022.11.016_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-008743","article-title":"Haemophagocytic syndrome with disseminated intravascular coagulation associated with tuberculosis","volume":"2013","author":"Cherif","year":"2013","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jiac.2022.11.016_bib12","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2169\/internalmedicine.56.8025","article-title":"Miliary tuberculosis in a young woman with hemophagocytic syndrome: a case report and literature review","volume":"56","author":"Asaji","year":"2017","journal-title":"Intern Med"},{"key":"10.1016\/j.jiac.2022.11.016_bib13","article-title":"Miliary tuberculosis-related acute respiratory distress syndrome complicated with hemophagocytic lymphohistiocytosis syndrome","volume":"2019","author":"Shiu","year":"2019","journal-title":"Case Rep Infect Dis"},{"key":"10.1016\/j.jiac.2022.11.016_bib14","article-title":"Hemophagocytic lymphohistiocytosis induced cytokine storm secondary to human immunodeficiency virus associated miliary tuberculosis","volume":"12","author":"Parsi","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.jiac.2022.11.016_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/omcr\/omaa082","article-title":"Tuberculosis-associated HLH in a patient with chronic kidney disease on haemodialysis","volume":"2020","author":"Shoureshi","year":"2020","journal-title":"Oxf Med Case Rep"},{"key":"10.1016\/j.jiac.2022.11.016_bib16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s13256-020-02555-x","article-title":"Hemophagocytic lymphohistiocytosis and miliary tuberculosis in a previously healthy individual: a case report","volume":"14","author":"Trovik","year":"2020","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.jiac.2022.11.016_bib17","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/mrcr\/rxab026","article-title":"Haemophagocytic lymphohistiocytosis in a patient with familial Mediterranean fever and miliary tuberculosis: a case report","volume":"6","author":"Cerme","year":"2022","journal-title":"Mod Rheumatol Case Rep"},{"key":"10.1016\/j.jiac.2022.11.016_bib18","doi-asserted-by":"crossref","DOI":"10.1093\/omcr\/omab142","article-title":"Miliary tuberculosis complicated with acute respiratory distress syndrome and hemophagocytic syndrome","volume":"2022","author":"Takahashi","year":"2022","journal-title":"Oxf Med Case Rep"},{"key":"10.1016\/j.jiac.2022.11.016_bib19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00277-011-1239-7","article-title":"Possible prediction of underlying lymphoma by high sIL-2R\/ferritin ratio in hemophagocytic syndrome","volume":"91","author":"Tabata","year":"2012","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jiac.2022.11.016_bib20","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00277-013-1925-8","article-title":"A high sIL-2R\/ferritin ratio is a useful marker for the diagnosis of lymphoma-associated hemophagocytic syndrome","volume":"93","author":"Tsuji","year":"2014","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jiac.2022.11.016_bib21","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1183\/09031936.95.08010070","article-title":"Elevated interleukin-2 receptor level in patients with active pulmonary tuberculosis and the changes following anti-tuberculosis chemotherapy","volume":"8","author":"Chan","year":"1995","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jiac.2022.11.016_bib22","first-page":"580","article-title":"Evaluation of the polymerase chain reaction in the diagnosis of miliary tuberculosis in bone marrow smear","volume":"7","author":"Escobedo-Jaimes","year":"2003","journal-title":"Int J Tubercul Lung Dis"},{"key":"10.1016\/j.jiac.2022.11.016_bib23","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1111\/j.1538-7836.2004.00927.x","article-title":"Phase I study of a novel recombinant human soluble thrombomodulin, ART","volume":"2","author":"Moll","year":"2004","journal-title":"J Thromb Haemostasis"},{"key":"10.1016\/j.jiac.2022.11.016_bib24","doi-asserted-by":"crossref","first-page":"11199","DOI":"10.1074\/jbc.C100017200","article-title":"Gene expression profile of antithrombotic protein C defines new mechanisms modulating inflammation and apoptosis","volume":"276","author":"Joyce","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jiac.2022.11.016_bib25","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.4049\/jimmunol.153.8.3664","article-title":"Selective inhibitory effects of the anticoagulant activated protein C on the responses of human mononuclear phagocytes to LPS, IFN-gamma, or phorbol ester","volume":"153","author":"Grey","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.jiac.2022.11.016_bib26","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.4049\/jimmunol.177.4.2115","article-title":"Modulation of monocyte function by activated protein C, a natural anticoagulant","volume":"177","author":"Stephenson","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jiac.2022.11.016_bib27","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1189\/jlb.1212662","article-title":"The many faces of HMGB1: molecular structure-functional activity in inflammation, apoptosis, and chemotaxis","volume":"93","author":"Yang","year":"2013","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jiac.2022.11.016_bib28","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.smim.2018.02.011","article-title":"High-mobility group box 1 protein (HMGB1) operates as an alarmin outside as well as inside cells","volume":"38","author":"Andersson","year":"2018","journal-title":"Semin Immunol"},{"key":"10.1016\/j.jiac.2022.11.016_bib29","first-page":"878","article-title":"Expression of serum HMGB-1 in patients with secondary hemo-phagocytic lymphohistiocytosis and its clinical significance","volume":"24","author":"Wang","year":"2016","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.jiac.2022.11.016_bib30","first-page":"301","article-title":"Serum high mobility group box protein 1 (HMGB1) levels reflect clinical features of childhood hemophagocytic lymphohistiocytosis","volume":"10","author":"Tsujimoto","year":"2019","journal-title":"Hematol Res Rev"},{"key":"10.1016\/j.jiac.2022.11.016_bib31","first-page":"1190","article-title":"Successful treatment with recombinant thrombomodulin for B-cell lymphoma-associated hemophagocytic syndrome complicated by disseminated intravascular coagulation","volume":"6","author":"Uni","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.jiac.2022.11.016_bib32","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s12185-013-1450-5","article-title":"Recombinant human soluble thrombomodulin is active against hemophagocytic lymphohistiocytosis associated with acquired immunodeficiency syndrome","volume":"98","author":"Chi","year":"2013","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jiac.2022.11.016_bib33","first-page":"312","article-title":"Successful treatment with recombinant thrombomodulin for disseminated intravascular coagulation complicated with hemophagocytic syndrome","volume":"56","author":"Yamazaki","year":"2015","journal-title":"Rinsho Ketsueki"},{"key":"10.1016\/j.jiac.2022.11.016_bib34","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s00277-013-1819-9","article-title":"Recombinant human thrombopoietin is an effective treatment for thrombocytopenia in hemophagocytic lymphohistiocytosis","volume":"92","author":"Wang","year":"2013","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jiac.2022.11.016_bib35","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1055\/s-0030-1262205","article-title":"The etiologic role of infectious antigens in sarcoidosis pathogenesis","volume":"31","author":"Oswald-Richter","year":"2010","journal-title":"Semin Respir Crit Care Med"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X22003221?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X22003221?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:05:56Z","timestamp":1761159956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X22003221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1341321X22003221"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2022.11.016","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Miliary tuberculosis-associated hemophagocytic lymphohistiocytosis with a high level of soluble interleukin-2 receptor successfully treated with concomitant recombinant thrombomodulin: A case report","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2022.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}